MVM Partners reposted this
📣 PRESS RELEASE - eXmoor and Virica Biotech receive funding to improve AAV gene therapy manufacturing 📣 We are delighted to announce this collaborative Canada-UK project aimed at improving the manufacture of adeno-associated vectors (#AAV), a crucial component of #genetherapies. We will utilize Virica’s VSEs™, small molecules that have been shown to increase productivity of AAVs, leveraging our scale-up and process development expertise to identify top candidates and deploy them at commercial scale upon completion of the project next year. “We thank Innovate UK for supporting this project, which we believe will benefit not only our work but our entire industry – and most importantly, patients,” said Angela Osborne “The advisory services and funding provided by the National Research Council Canada / Conseil national de recherches Canada Industrial Research Assistance Program and our partnership with eXmoor create a great commercial opportunity to increase efficiency and reduce costs of life-saving therapies,” said Jean-Simon Diallo, co-founder and CEO of Virica Read the full press release below. https://lnkd.in/eCjf55tV